Mariapina Gallo
Biographic Data
| ID | 7181329 |
|---|---|
| NAME | Mariapina Gallo |
| GIVEN NAMES | Mariapina |
| FAMILY NAME | Gallo |
| SIGNATURE | GALLO M |
| AFFILIATIONS | Ospedale Papa Giovanni XXIII |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The impact of Covid-19 management on the risk of exposure to specific chemical products: A multicentric Italian study based on 2017–2021 poison centers consultancies
Introduction In Italy, the emergency of COVID-19 led to the promotion of preventive measures like hygiene protocols, biocides use, and lockdowns. This study assesses whether the Italian COVID-19 prevention Decrees led to significant changes in exposure to specific chemicals, also examining the post-COVID-19 period (2021). Materials and methods This multicentric observational study analyzed 2017–2021 exposure data to specific chemicals coming from…
Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression
The ensuing recommendations were as follows: Recommendation 1: Depressive and anxiety disorders, as well as their pharmacological treatment, are not contraindications for breastfeeding. Recommendation 2: The Panel advocates for the continuation of medication that has demonstrated efficacy during pregnancy. If initiating an antidepressant during breastfeeding is necessary, drugs with a superior safety profile and substantial epidemiological data, …
Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on t…
Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy
A number of new psychoactive substances (NPS) have been released in the last decade, and the list of NPS continues to grow. This paper reports a retrospective evaluation of the toxicological analyses in 1,445 suspected intoxication cases by psychostimulant, hallucinogen, and dissociative NPS occurring in hospitals across Italy from 2011 to 2019. The objectives of the study were to contribute to the monitoring of the NPS diffusion based on analyti…
No prominent works on this page.
Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy
A number of new psychoactive substances (NPS) have been released in the last decade, and the list of NPS continues to grow. This paper reports a retrospective evaluation of the toxicological analyses in 1,445 suspected intoxication cases by psychostimulant, hallucinogen, and dissociative NPS occurring in hospitals across Italy from 2011 to 2019. The objectives of the study were to contribute to the monitoring of the NPS diffusion based on analyti…
Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on t…
Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression
The ensuing recommendations were as follows: Recommendation 1: Depressive and anxiety disorders, as well as their pharmacological treatment, are not contraindications for breastfeeding. Recommendation 2: The Panel advocates for the continuation of medication that has demonstrated efficacy during pregnancy. If initiating an antidepressant during breastfeeding is necessary, drugs with a superior safety profile and substantial epidemiological data, …
The impact of Covid-19 management on the risk of exposure to specific chemical products: A multicentric Italian study based on 2017–2021 poison centers consultancies
Introduction In Italy, the emergency of COVID-19 led to the promotion of preventive measures like hygiene protocols, biocides use, and lockdowns. This study assesses whether the Italian COVID-19 prevention Decrees led to significant changes in exposure to specific chemicals, also examining the post-COVID-19 period (2021). Materials and methods This multicentric observational study analyzed 2017–2021 exposure data to specific chemicals coming from…
Medicine (3 works) · Psychiatry (3 works) · Maternal Mental Health During Pregnancy and Postpartum (2 works) · MEDLINE (2 works) · Alternative medicine (1 works) · Anxiety (1 works) · Breast feeding (1 works) · Breastfeeding (1 works) · Breastfeeding Practices and Influences (1 works) · Carcinogens and Genotoxicity Assessment (1 works)